On Wednesday, BMO Capital Markets adjusted its price target for Bath & Body Works Inc. (NYSE: BBWI), reducing it to $50 from the previous $52, while maintaining an Outperform rating on the stock. This change comes after the company reported earnings, revealing that while their earnings per share (EPS) slightly exceeded expectations, their revenue did not meet projections.
The firm's analysis noted that despite the top-line miss, Bath & Body Works' gross margin improved significantly, contributing to the EPS beat. Management's guidance for third-quarter sales was higher than analysts' expectations at the high end, though their EPS forecast was lower. The full-year EPS guidance was also adjusted downward, now sitting just above the consensus estimates.
In the report, BMO Capital acknowledged that there are concerns within the investor community about potential further reductions in financial guidance. Some investors might have anticipated a more conservative outlook as a precautionary measure. However, the firm expressed confidence in the company's future performance, suggesting that Bath & Body Works is currently underperforming and undervalued when looking ahead.
The analyst from BMO Capital highlighted the need to monitor the decline in EBIT (earnings before interest and taxes) but reiterated the Outperform rating. The new price target of $50 implies a valuation of approximately 13 times the projected earnings for the fiscal year 2025.
In other recent news, Bath & Body Works has seen a series of financial adjustments from various analyst firms. Piper Sandler and Citi revised the company's price target to $35, citing a challenging economic environment and difficulties in re-engaging customers. Despite a decline in sales, Bath & Body Works' management efforts to implement cost savings and improve margin performance have been recognized as positive steps. Evercore ISI also adjusted the company's price target, highlighting improved margins despite lower sales.
BMO Capital maintained its Outperform rating on Bath & Body Works, emphasizing the company's improved gross margins despite revenue shortfalls. The company's future revenue growth is anticipated to be at the higher end of expectations, although earnings projections are conservatively set. Telsey Advisory Group also reiterated its Outperform rating on Bath & Body Works, highlighting the company's strong first quarter performance, which showcased solid top-line growth and a bottom-line beat.
InvestingPro Insights
In light of the recent adjustments by BMO Capital Markets, it's worth considering additional insights provided by InvestingPro. Bath & Body Works Inc. (NYSE: BBWI) is currently trading at a low P/E ratio of 8.28, which, when compared to its near-term earnings growth, suggests the stock may be undervalued. This aligns with BMO Capital's view that the company is underperforming and undervalued.
Moreover, Bath & Body Works has demonstrated a commitment to returning value to shareholders, maintaining dividend payments for 52 consecutive years, with a current dividend yield of 2.3%. This may appeal to income-focused investors, especially in a volatile market environment where BBWI's stock price movements have been quite volatile, with a significant price drop over the last three months.
Despite a slight revenue decline over the last twelve months, analysts predict the company will remain profitable this year, which could reassure investors looking for stability in earnings. For those interested in further analysis and insights, InvestingPro offers additional tips on Bath & Body Works, which can be accessed for more in-depth investment considerations.
InvestingPro also provides a fair value estimate of $47.62 for BBWI, which is below the analyst target but still above the current market price, indicating potential upside. To explore the full range of InvestingPro Tips and gain a comprehensive understanding of BBWI's investment potential, visit InvestingPro's dedicated page for the company.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.